Science Explorer Back to mapMap
Discussion
Topic · Rehabilitation

Magnolia and Illicium research

Magnolia and Illicium research is a research topic within Rehabilitation. Science Explorer counts 3.2k research works in it since 1951. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the therapeutic applications of honokiol and magnolol compounds, derived from the Magnolia family. The research covers a wide range of potential uses, including anticancer, neuroprotective, anti-inflammatory, and antioxidative properties. These compounds have shown promising effects in inducing apoptosis, inhibiting angiogenesis, and serving as chemotherapy candidates for various diseases.

  • Honokiol
  • Magnolia Family
  • Anticancer
  • Neuroprotective
  • Anti-inflammatory
  • Antioxidative
  • Apoptosis Induction
  • Angiogenesis Inhibition
  • Chemotherapy Candidate
  • Natural Product
Research works
3.2k
fractional, since 1951
In the world top 10%
320
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+19%
the tick is no change
Largest producer
China
68% of the 10 largest, 2022-now
Magnolia and Illicium research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Magnolia and Illicium research research?

By volume, China and India publish the most (478 and 55 works in 2022-now).

By volume, 2022-now

  1. 1 China 478 works
  2. 2 India 55 works
  3. 3 South Korea 40 works
  4. 4 United States 36 works
  5. 5 Japan 20 works
  6. 6 Taiwan 19 works
  7. 7 Iran 18 works
  8. 8 Italy 13 works
  9. 9 Türkiye 12 works
  10. 10 Poland 12 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 68.0%India: 7.8%South Korea: 5.7%United States: 5.1%6 others listed: 13.4%68%largest
China478 · 68.0%India55 · 7.8%South Korea40 · 5.7%United States36 · 5.1%6 others listed94 · 13.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Magnolia and Illicium research research?

By volume in 2022-now, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Magnolia and Illicium research research, followed by Nanjing University of Chinese Medicine and Chengdu University of Traditional Chinese Medicine.

By volume, 2022-now

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
  2. 2 Nanjing University of Chinese MedicineChina 10 works
  3. 3 Chengdu University of Traditional Chinese MedicineChina 9 works
  4. 4 Chinese Academy of SciencesChina 8 works
  5. 5 Shanghai University of Traditional Chinese MedicineChina 7 works
  6. 6 Sichuan UniversityChina 7 works
  7. 7 Shanghai Jiao Tong UniversityChina 6 works
  8. 8 Beijing University of Chinese MedicineChina 6 works
  9. 9 Nanjing Medical UniversityChina 5 works
  10. 10 Zhejiang Chinese Medical UniversityChina 5 works

Who are the leading researchers in Magnolia and Illicium research?

The most-cited researchers publishing on Magnolia and Illicium research include Kendall N. Houk.

  1. 1 Kendall N. Houk United States 123k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Magnolia and Illicium research?

The most cited paper in Magnolia and Illicium research is "Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy" (Savita Bisht, Georg Feldmann, Sheetal Soni et al., 2007), with 1,094 citations. Next come "Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress" (837) and "Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol" (745).

Most cited papers
#PaperReleasedCitations
1 Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy Savita Bisht, Georg Feldmann, Sheetal Soni et al. · Journal of Nanobiotechnology Open access 17 Apr 2007 1,094
2 Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress Qing Zhang, Jia Liu, Huxinyue Duan et al. · Journal of Advanced Research Open access 6 Jul 2021 837
3 Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol Swarnalatha Dugasani, Mallikarjuna Rao Pichika, Vishna Devi Nadarajah et al. · Journal of Ethnopharmacology 14 Oct 2009 745
4 Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine Xiaofei Shang, Pan Hu, Maoxing Li et al. · Journal of Ethnopharmacology Open access 16 Aug 2011 615
5 Best practice in research – Overcoming common challenges in phytopharmacological research Michael Heinrich, Giovanni Appendino, Thomas Efferth et al. · Journal of Ethnopharmacology Open access 14 Sep 2019 607
All 99 most cited papers, with filters and sorting

Where is Magnolia and Illicium research research done?

The largest centres of Magnolia and Illicium research research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Chengdu and Guangzhou.

Largest cities, 2022-now

  1. 1 BeijingChina 51 works
  2. 2 GuangzhouChina 29 works
  3. 3 ShanghaiChina 28 works
  4. 4 NanjingChina 25 works
  5. 5 ChengduChina 24 works
  6. 6 SeoulSouth Korea 18 works
  7. 7 WuhanChina 15 works
  8. 8 HangzhouChina 14 works
  9. 9 ShenyangChina 11 works
  10. 10 Xi'anChina 11 works

Where it is the local speciality

  1. ChengduCN · 23.7 works4.3×
  2. GuangzhouCN · 29.3 works4.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Magnolia and Illicium research than the world average.

See Magnolia and Illicium research on the map

Where is the best place to study Magnolia and Illicium research?

Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing University of Chinese Medicine score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chengdu University of Traditional Chinese MedicineChina 50.025.8%46.8×9 +30.3%
2Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44.65.3%17.7×14 -1.4%
3Nanjing University of Chinese MedicineChina 35.911.8%53.2×10 +100.2%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Magnolia and Illicium research, country by country

Is Magnolia and Illicium research research growing?

Output in 2022-2025 was 19% higher than in 2018-2021, peaking in 2026. The fastest-growing topics are Magnolia and Illicium research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Magnolia and Illicium research as a percentage of every work published that year, 0.0026% in 2024.

still counting0.0020%0.0040%0.0060%Magnolia and Illicium research0.0036% in 202519801990200020102020

Fractional works of Magnolia and Illicium research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Magnolia and Illicium research9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Magnolia and Illicium research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.